Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- MITK -5.5%, PNC -0.7%, CFB -0.5%, NTRS -0.5%, JNJ -0.4%
Other news:
- INO -21.5% (prices $36 mln offering consisting of stock and warrants)
- WRN -4.9% (announces $25 million bought deal public offering)
- DOOO -3.5% (bought deal secondary offering)
- NVST -3.3% (names new CEO)
- WTFC -2.3% (enters into merger agreement with MCBC)
- GRPN -2.3% (expects Q1 revs and adjusted EBITDA at or above high end of guidance)
- TSLA -2.3% (confirms company-wide restructuring that reduces our headcount by more than 10% globally and Andrew Baglino resignation)
- ARGX -2% (Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease)
- SPT -1.7% (names new CEO; current CEO to become Executive Chair)
- VALE -1.3% (informs on the Pará State Court's decision about the Sossego Mine; informs a change in the Audit and Risks Committee's composition)
- GSK -1.1% (receives FDA acceptance for meningitis vaccine candidate file)
- FTI -1% (awarded contract by XOM affiliate)